Medication against schizophrenia inhibits pancreatic cancer — McGill University Newsroom

A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer — and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center.

Read more via the source: Medication against schizophrenia inhibits pancreatic cancer — Newsroom – News releases

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s